Revenues should be higher considering that Aphria acquired CC Pharma, a leading German Pharmaceutical and Medical Cannabis Distributor During 2018, CC Pharma generated revenue of approximately $262 million (euros), with EBITDA of approximately $10.5 million. APHRIA's next financial report should be over $100 million, considering that CC pharma generates around 65 mil euros per quarter + Aphria